Home › Funds › Balyasny Asset Management › FOLD
Balyasny Asset Management position in FOLD
AMICUS THERAPEUTIC
Latest position (Q1 2026)3.83M sh
Reported value held$55.35M
Portfolio Weight0.08%
First reportedQ2 2022
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2022 | 2.15M | $23.12M | New |
| Q3 2022 | 1.68M | $17.59M | Reduce |
| Q4 2022 | 2.00M | $24.42M | Add |
| Q1 2023 | 2.12M | $23.50M | Add |
| Q2 2023 | 3.23M | $40.51M | Add |
| Q3 2023 | 3.39M | $41.17M | Add |
| Q4 2023 | 1.56M | $22.09M | Reduce |
| Q2 2024 | 1.12M | $11.08M | New |
| Q3 2024 | 2.06M | $22.05M | Add |
| Q4 2024 | 849.40K | $8.00M | Reduce |
| Q1 2025 | 903.23K | $7.37M | Add |
| Q2 2025 | 421.81K | $2.42M | Reduce |
| Q3 2025 | 1.38M | $10.85M | Add |
| Q4 2025 | 5.18M | $73.82M | Add |
| Q1 2026 | 3.83M | $55.35M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding FOLD
- Vanguard Group 29.70M sh · $422.97M · Q4 2025
- Janus Henderson Group 1.07M sh · $15.52M · Q1 2026